← 홈

전체 프로그램

ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-13 · 마지막 7월 13일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 188개
AntibodystaleRochePreclinical

Capecitabine (Xeloda, Capecitabine, Capecitabine (Xeloda), Oxaliplatin, Irinotecan, Bevacizumab)

Metastatic Colorectal Cancer · Metastatic Colorectal Cancer

#MetastaticColorectalCancer#Antibody#Preclinical#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleUniversity of Medicine and Dent…Phase 2

Capecitabine and Cetuximab (Capecitabine and Cetuximab)

Colorectal Cancer · Colorectal Cancer

#ColorectalCancer#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 DISCONTINUED
AntibodystaleRochePhase 3

Capecitabine plus bevacizumab (Capecitabine plus bevacizumab)

Elderly Patients; Metastatic Colorectal Cancer · Elderly Patients

#ElderlyPatients#Antibody#Phase3#항체#면역항체+3
임상시험 1상태 RECRUITING
AntibodystaleEli LillyPhase 2

Erbitux, C225 (Cetuximab, Cetuximab (Erbitux, C225))

Colorectal Cancer Metastatic · Colorectal Cancer Metastatic

#ColorectalCancerMetastatic#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleEli LillyPhase 2

Cetuximab + Afatinib (Cetuximab + Afatinib)

Metastatic Colorectal Cancer · Metastatic Colorectal Cancer

#MetastaticColorectalCancer#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleEli LillyPhase 2

Cetuximab + Envafolimab + mFOLFOXIRI (Cetuximab + Envafolimab + mFOLFOXIRI)

Metastatic Colorectal Cancer · Metastatic Colorectal Cancer

#MetastaticColorectalCancer#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleEli LillyPhase 1

Cetuximab - Cohort Expansion (Cetuximab - Cohort Expansion)

Colorectal Cancer Metastatic; Squamous Cell Carcinoma of Head and Neck · Colorectal Cancer Metastatic

#ColorectalCancerMetastatic#Antibody#Phase1#항체#면역항체+3
임상시험 1상태 RECRUITING
AntibodystaleEli LillyPhase 1

Cetuximab - Dose Escalation (Cetuximab - Dose Escalation)

Colorectal Cancer Metastatic; Squamous Cell Carcinoma of Head and Neck · Colorectal Cancer Metastatic

#ColorectalCancerMetastatic#Antibody#Phase1#항체#면역항체+3
임상시험 1상태 RECRUITING
AntibodystaleEli LillyPreclinical

trastuzumab (Herceptin, Cetuximab Ab; Bevacizumab; Vermofenib + cetuximab;Trastuzumab+lapatinib or trastuzumab+pertuzumab; others)

Metastatic Colorectal Cancer · Metastatic Colorectal Cancer

#MetastaticColorectalCancer#Antibody#Preclinical#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleEli LillyPreclinical

Cetuximab Dabrafenib Tislelizumab (Cetuximab Dabrafenib Tislelizumab)

Advanced Colorectal Cancer · Advanced Colorectal Cancer

#AdvancedColorectalCancer#Antibody#Preclinical#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleEli LillyPhase 1

Cetuximab Injection [Erbitux] (Cetuximab Injection [Erbitux])

BRAF V600E-mutated /MSS Metastatic Colorectal Cancer; Vemurafenib (BRAFi) Plus Cetuximab (EGFRi) Combined With PD-1 Mon… · EGFR

#EGFR#Antibody#Phase1#항체#면역항체+5
임상시험 1상태 ACTIVE
AntibodystaleEli LillyPhase 2

Cetuximab and FOLFIRI (Cetuximab and FOLFIRI)

Colorectal Cancer; Liver Metastases · Colorectal Cancer

#ColorectalCancer#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleEli LillyPhase 2

Cetuximab and FOLFOX (Cetuximab and FOLFOX)

Colorectal Cancer; Liver Metastases · Colorectal Cancer

#ColorectalCancer#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleEli LillyPhase 3

Cetuximab wkly (Cetuximab wkly)

Metastatic Colorectal Cancer · Metastatic Colorectal Cancer

#MetastaticColorectalCancer#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleEli LillyPhase 2

Cetuximab, Oxaliplatin, Leucovorin, 5FU, Irinotecan (Cetuximab, Oxaliplatin, Leucovorin, 5FU, Irinotecan)

Metastatic Colorectal Cancer · Metastatic Colorectal Cancer

#MetastaticColorectalCancer#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleEli LillyPhase 1

Cetuximab/Gefitinib combination and/or monotherapy (Cetuximab/Gefitinib combination and/or monotherapy)

Colorectal Cancer; Head and Neck Cancer · Colorectal Cancer

#ColorectalCancer#Antibody#Phase1#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleRochePreclinical

Chidamide, Tucidinostat; PD-1/PD-L1 inhibitor or double antibodies; Bevacizumab or tyrosine kinase inhibitors (Chidamide, Tucidinostat; PD-1/PD-L1 inhibitor or double antibodies; Bevacizumab or tyrosine kinase inhibitors)

Colorectal Cancer Metastatic · PD-1

#PD-1#Antibody#Preclinical#항체#면역항체+3
임상시험 1상태 RECRUITING
AntibodystaleHoffmann-La RochePhase 1

Cibisatamab (Cibisatamab)

Colorectal Cancer · Colorectal Cancer

#ColorectalCancer#Antibody#Phase1#항체#면역항체+2
임상시험 1상태 DISCONTINUED
AntibodystaleChinese PLA General HospitalPhase 2

Colorectal cancer: Tunlametinib + cetuximab β (Colorectal cancer: Tunlametinib + cetuximab β)

Treatment for Advanced Colorectal Cancer; Treatment for Advanced Pancreatic Cancer · Treatment for Advanced Colorectal Cancer

#TreatmentforAdvancedColorectalCa#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 RECRUITING
AntibodystaleKahr Bio Australia Pty LtdPhase 2

atezolizumab (Tecentriq, DSP107 + Atezolizumab)

Colorectal Cancer · Colorectal Cancer

#ColorectalCancer#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 RECRUITING

5 / 10 페이지

← 이전다음 →